Master in Molecular Pathology and Immunology

Rowan University, founded in 1923 and based in Glassboro, is known for combining strong academic programs with applied research and community engagement. Enrolling nearly 19,600 students, including international learners, Rowan emphasizes hands-on learning, innovation and preparation for professional careers. The university offers a wide array of undergraduate and graduate programs across disciplines and encourages students to integrate research, internships and service into their studies.

Rowan's educational approach highlights experiential projects, close faculty mentoring and partnerships that connect classroom learning to real-world challenges. Students frequently participate in research initiatives, industry collaborations and community-focused work that enhance employability and practical skills. The campus culture promotes collaboration, leadership development and opportunities to engage with faculty on applied research.

International and domestic students alike find support through advising, career services and campus activities designed to ease academic transition and professional development. Prospective students seeking a university with a clear emphasis on career readiness, applied learning and meaningful community connections will find Rowan offers a balance of academic rigor and practical experience to launch successful careers.

The Master in Molecular Pathology and Immunology at Rowan University is a Master's degree for students who want to work in diagnostic, immunology, or pathology laboratories. This 1-2 year program helps students gain lab experience and work with leading researchers.

The curriculum includes hands-on training in molecular biology and immunology. Students learn about lab techniques, data analysis, and research methods. They also develop skills in scientific writing, critical thinking, and problem-solving.

Graduates can pursue careers as Laboratory Managers, Research Scientists, Immunologists, or Molecular Biologists. They can work in hospitals, research institutions, or pharmaceutical companies, applying their knowledge to develop new treatments and therapies.